Elevate Uranium reports successful pilot plant testing results

• Elevate Uranium completed pilot plant testing for its proprietary U-pgrade beneficiation process, confirming successful operation across all targeted metallurgical parameters.
• Shares of the company traded lower following the market update, dropping 7.8%.
• The trial aims to significantly reduce capital and operating costs for the company's flagship Koppies uranium project.

Elevate Uranium (ASX:EL8) announced positive operational test results from its continuous U-pgrade demonstration pilot plant.

The trial results met internal design expectations, surpassing previous laboratory-scale benchmarks.

"All five unit operations performed continuously and seamlessly together, validating the performance of our patented process," said Elevate Uranium Managing Director Murray Hill.

The pilot processing unit successfully reduced total ore mass by up to 80% while retaining high uranium recovery rates.

The company stated that the confirmed metallurgical performance will form the baseline design for its planned full-scale development facility.

Following the announcement, the Elevate Uranium share price was down at $0.27.

Elevate Uranium is an Australian mineral exploration company primarily focused on developing nuclear fuel resources in Namibia and Australia.

The business holds an expanded global resource base containing over 120 million pounds of triuranium octoxide.